United States News Todas as matérias

Netflix (NASDAQ:NFLX) has secured up to $25 billion in bank financing to fund its proposed $72 billion acquisition of Warner Bros. Discovery’s movie studio and HBO Max streaming business.

Adeia (NASDAQ:ADEA), the Silicon Valley intellectual property powerhouse, dramatically raised its full-year 2025 financial outlook on Monday after securing a long-term media IP license agreement with The Walt Disney Company (NYSE:DIS).

Helix Energy Solutions Group (NYSE:HLX) has secured a significant multi-year contract with a major operator for riserless plug and abandonment (P&A) operations on up to 34 subsea wells in the UK North Sea.

CACI International (NYSE:CACI) has agreed to acquire ARKA Group L.P. from funds managed by Blackstone Tactical Opportunities in an all-cash transaction valued at $2.6 billion.

FreightCar America (NASDAQ:RAIL) completed the acquisition of Carly Railcar Components on Monday, a strategic move designed to accelerate the expansion of its high-margin aftermarket business.

Baytex Energy Corp. (NYSE:BTE) has announced its 2026 budget, outlining plans for production growth, strategic shareholder returns, and significant leadership changes. The company targets a 3%–5% production growth in Canada for the upcoming year, with an expected average production of 67,000–69,000 barrels of oil equivalent per day (boe/d), based on a US$60 WTI price.

Vertical Aerospace (NYSE:EVTL), the British developer of electric vertical take-off and landing (eVTOL) aircraft, has reached a critical milestone in its path toward commercial flight.

The GEO Group (NYSE:GEO), a leading provider of government-contracted services, announced on Monday that its wholly-owned subsidiary, BI Incorporated, has been awarded a significant new contract by U.S. Immigration and Customs Enforcement (ICE).

Parsons Corporation (NYSE:PSN) has secured a $30 million contract expansion and a strategic novation to the U.S. Space Development Agency (SDA), marking a major transition for the Department of Defense’s "Blackjack" satellite program.

Greenwich LifeSciences (NASDAQ:GLSI) provided a comprehensive year-end update on Monday for its pivotal Phase III clinical trial, FLAMINGO-01.

The trial is evaluating GLSI-100, a Fast Track-designated immunotherapy designed to prevent breast cancer recurrence in HER2-positive patients.

Honeywell International (NASDAQ:HON) issued a comprehensive update to its financial projections on Monday, recalibrating its 2025 guidance to account for the strategic spin-off of its Advanced Materials business.

KalVista Pharmaceuticals (NASDAQ:KALV) has received marketing and manufacturing approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for EKTERLY (sebetralstat), establishing it as the first and only oral on-demand treatment for hereditary angioedema (HAE) in the country.

Ennis (NYSE:EBF), a major manufacturer of printed business products, reported an increase in third-quarter profitability on Monday, as significant margin expansion helped the company overcome a softer nine-month revenue trend.

Uber Technologies (NYSE:UBER) and Lyft (NASDAQ:LYFT) are joining forces with Chinese tech giant Baidu (NASDAQ:BIDU) to launch driverless taxi trials in the United Kingdom next year, a strategic pivot that intensifies the global race to commercialize autonomous mobility.

STMicroelectronics NV (NYSE:STM) has entered a strategic agreement with Italian robotics firm Oversonic to integrate cognitive humanoid robots into its global manufacturing and logistics network.

Alvotech (NASDAQ:ALVO) achieved a significant milestone in the competitive biologics market on Monday, announcing the European debut of Gobivaz, the first biosimilar to the blockbuster inflammatory drug Simponi to reach the market anywhere in the world.

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo have secured their tenth Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration for ENHERTU, marking a pivotal step in moving the blockbuster treatment into earlier, potentially curative stages of breast cancer.

Incyte Biosciences Japan G.K. has secured regulatory clearance from Japan’s Ministry of Health, Labour and Welfare for Minjuvi, marking the first time a dual-targeted CD19 and CD20 immunotherapy combination has been authorized for patients with follicular lymphoma in the country.

Samsung Biologics, the world’s leading contract development and manufacturing organization, has reached an agreement to acquire Human Genome Sciences from GSK (NYSE:GSK), marking the South Korean firm’s first physical manufacturing footprint in the United States.

Telix Pharmaceuticals (NASDAQ:TLX) moved closer to expanding its global footprint in precision medicine on Sunday, reporting successful Phase 3 results for its flagship prostate cancer imaging agent in China and clearing regulatory hurdles for its broader pipeline in the United States.

Brazil’s B3 plans to launch a stablecoin in 2026 as new details emerge around Libra’s launch and Nubank weighs a bank acquisition amid tightening regulation.

IMF COFER data shows central banks largely maintained US dollar reserves in Q2 2025, challenging dedollarization narratives often cited as bullish for Bitcoin.

The Federal Reserve is set to inject $6.8 billion via its first repo operation since 2020, easing year-end liquidity strains and drawing attention from crypto markets.

Northern Data has sold its Bitcoin mining arm to companies linked to Tether executives, highlighting deepening financial ties across the crypto and data centre sector.